Reply to R. Sun et al

Affiliations

¹ Jonathan L. Moore, FRCS, Department of Upper Gastrointestinal and General Surgery, Guy's & St Thomas' NHS Foundation Trust, London, United Kingdom, School of Cancer and Pharmaceutical Sciences, King's College London, London, United Kingdom; Aida Santaolalla, PhD, Mieke Van Hemelrijck, PhD, and Bernard North, PhD, School of Cancer and Pharmaceutical Sciences, King's College London, London, United Kingdom; and Andrew R. Davies, MD, FRCS, Department of Upper Gastrointestinal and General Surgery, Guy's & St Thomas' NHS Foundation Trust, London, United Kingdom, School of Cancer and Pharmaceutical Sciences, King's College London, London, United Kingdom.

Comment

Jonathan L Moore et al. J Clin Oncol. 2024.

. 2024 Jan 20;42(3):367-368.

doi: 10.1200/JCO.23.02131. Epub 2023 Nov 21.

¹ Jonathan L. Moore, FRCS, Department of Upper Gastrointestinal and General Surgery, Guy's & St Thomas' NHS Foundation Trust, London, United Kingdom, School of Cancer and Pharmaceutical Sciences, King's College London, London, United Kingdom; Aida Santaolalla, PhD, Mieke Van Hemelrijck, PhD, and Bernard North, PhD, School of Cancer and Pharmaceutical Sciences, King's College London, London, United Kingdom; and Andrew R. Davies, MD, FRCS, Department of Upper Gastrointestinal and General Surgery, Guy's & St Thomas' NHS Foundation Trust, London, United Kingdom, School of Cancer and Pharmaceutical Sciences, King's College London, London, United Kingdom.

No abstract available

Comment on

Assessing Predictability of Pathologic Lymph Node Regression for Recurrence and Survival in Esophageal Adenocarcinoma.
Sun R, Liu J, Wei LJ. Sun R, et al. J Clin Oncol. 2024 Jan 20;42(3):366. doi: 10.1200/JCO.23.01785. Epub 2023 Nov 21. J Clin Oncol. 2024. PMID: 37988644 No abstract available.